ライフサイエンスコーパス: Mycoplasma

1 ibody-binding protein (Protein M) from human mycoplasma.

2 se synthesis that is widespread in the genus Mycoplasma.

3 Prevotella, Selenomonas, Streptococcus, and Mycoplasma.

4 nisms of the myxobacteria, flavobacteria and mycoplasmas.

5 entially key role in the immunity evasion by mycoplasmas.

6 nucleotide sequence motifs of the hemotropic Mycoplasma 16S rRNA and RNase P genes indicate the prese

7 Treponema (34%), Mycoplasma (29%) and Porphyromonas (15%) were the most a

8 colonization yet cilia provide a conduit for mycoplasma access to the host cell surface and suggest a

9 We created heterogeneity in Mycoplasma agassizii exposure (the putative bacterial ag

10 We show here that mycoplasmas also produce glycoproteins and hence have gl

11 Mycoplasma amphoriforme has been associated with infecti

12 Mycoplasma amphoriforme is a recently described organism

13 Mycoplasma amphoriforme isolates form a closely related

14 sis, we observed infrequent co-occurrence of Mycoplasma and bacteria vaginosis associated bacteria 3

15 s of cells hyper-susceptible to infection by Mycoplasma and Mycobacterium bovis Bacillus Calmette-Gue

16 acking the 3G-C pairs, as in some species of Mycoplasma and Rhizobium, is puzzling.

17 2) is a by-product of glycerol metabolism in mycoplasmas and has been shown to cause cytotoxicity for

18 encoding the MIB-MIP system are specific to mycoplasmas and have been disseminated by horizontal gen

19 homologs found in the majority of pathogenic mycoplasmas and often in multiple copies.

20 sure accurate and reliable assay results for mycoplasmas and ureaplasmas that infect humans.

21 e bacilli, Staphylococcus aureus, Chlamydia, Mycoplasma, and Legionella are each identified in 2%-5%

22 e genera Methylobacterium, Acinetobacter and Mycoplasma, appear to drive these changes, indicating th

23 ing knowledge that species of Mannheimia and Mycoplasma are important pathogens in pneumonia and otit

24 Within the genus Mycoplasma are species whose cells have terminal organel

25 Mycoplasmas are "minimal" bacteria able to infect humans

26 Mycoplasmas are notorious contaminants of cell culture a

27 glycoprotein stain, and the murine pathogen Mycoplasma arthritidis was chosen for further study.

28 Mycoplasma arthritidis-derived mitogen (MAM) is a member

29 s, and in both the d and l configurations in Mycoplasma arthritidis.

30 ine, 2'-deoxyuridine and thymidine inhibited mycoplasma-associated dFdC deamination but were efficien

31 Mycoplasma bacteria, with the smallest known genomes amo

32 Mycoplasma bovis is a major bovine pathogen associated w

33 al diarrhea virus, Mannheimia haemolytica or Mycoplasma bovis.

34 Unique among mycoplasmas, Ca.

35 Mycoplasma canis can infect many mammalian hosts but is

36 ial to cause invasive disease, the genome of Mycoplasma canis strain PG14(T) from a dog's throat was

37 The minimalist bacterium Mycoplasma capricolum possesses two homologs of trmFO, b

38 , Mycoplasma mycoides subsp. capri (Mmc) and Mycoplasma capricolum subsp. capricolum (Mcap), and the

39 PP) is a highly contagious disease caused by Mycoplasma capricolum subsp. capripneumoniae that affect

40 Mycoplasmas cause chronic respiratory diseases in animal

41 Mycoplasmas cause numerous human diseases and are common

42 s cluster are among the most virulent of the mycoplasmas, causing worldwide economically significant

43 e advantage of the special properties of the mycoplasma cell reveal that this motor propels cells in

44 sma, cytoplasm, synaptic vesicles, HIV and a mycoplasma cell.

45 This study reveals a metabolically unique mycoplasma colonizing a premature neonate, and establish

46 fected tumor cells release exosomes carrying mycoplasma components that preferentially activate B cel

47 ent culture medium (i.e. tumor cell-free but mycoplasma-containing) of mycoplasma-infected tumor cell

48 sent a simple and sensitive assay to monitor mycoplasma contamination (mycosensor) based on degradati

49 Lastly, we examined the relationship between mycoplasma contamination and host gene expression in a s

50 Mycoplasma contamination in mammalian cell cultures is o

51 available bioluminescent assay in detecting mycoplasma contamination in seven different cell lines.

52 In all, this study suggests mycoplasma contamination is still prevalent today and po

53 ity of dFdC in such cells is attributed to a mycoplasma cytidine deaminase causing rapid drug catabol

54 Adherence assays with radiolabeled mycoplasmas demonstrated a dramatic reduction in binding

55 Additionally, mycoplasma-derived pyrimidine nucleoside phosphorylase (

56 eir ability to modulate adaptive immunity in mycoplasma disease are currently unknown.

57 e cells may influence either exacerbation of mycoplasma disease pathogenesis or enhancement of protec

58 to the activation of T cell responses during mycoplasma disease pathogenesis.

59 ection as well as promote immunopathology in mycoplasma disease.

60 amplification (LAMP) system, the illumigene Mycoplasma DNA amplification assay (Meridian Bioscience,

61 A mycoplasma-encoded purine nucleoside phosphorylase (desi

62 changes in the defunct editing domain of the Mycoplasma enzyme were sufficient to restore E. coli gro

63 ation sequencing technology in applied avian mycoplasma epidemiology at both local and global levels.

64 Ss are naturally error prone, most notably a Mycoplasma example that displayed a low level of specifi

65 Elimination of the mycoplasma from the tumor cell cultures or selective inh

66 ost immune characteristics drive patterns of Mycoplasma gallisepticum (MG) infections in the house fi

67 ches and the conjunctival bacterial pathogen Mycoplasma gallisepticum (MG), to experimentally examine

68 ion using archived isolates of the bacterium Mycoplasma gallisepticum collected during sequential eme

69 Mycoplasma gallisepticum colonizes the chicken respirato

70 h management, vaccination, and surveillance, Mycoplasma gallisepticum continues to cause significant

71 ype (WT) R(low) strain of the avian pathogen Mycoplasma gallisepticum is capable of producing H2O2 wh

72 Mycoplasma gallisepticum is the most virulent and econom

73 Mycoplasma gallisepticum is the primary etiologic agent

74 nome-scale metabolic model for the bacterium Mycoplasma gallisepticum was created.

75 Mycoplasma gallisepticum, known primarily as a respirato

76 Mycoplasma gallisepticum, the primary etiologic agent of

77 sease, Mycoplasmal conjunctivitis, caused by Mycoplasma gallisepticum.

78 Two affiliated close to Spiroplasma and Mycoplasma genera, one to chlamydial 'Candidatus Syngnam

79 Mycoplasma genitalium (MG) is an emerging sexually trans

80 Mycoplasma genitalium (MG) is associated with nongonococ

81 Chlamydia trachomatis (CT), Mycoplasma genitalium (MG), and Trichomonas vaginalis (T

82 e was tested for Chlamydia trachomatis (CT), Mycoplasma genitalium (MG), Ureaplasma urealyticum biova

83 To determine the prevalence of Mycoplasma genitalium and its association with cervical

84 The relatively high prevalence of Mycoplasma genitalium and its association with prevalent

85 Mycoplasma genitalium and other NGU pathogens were detec

86 ae and to determine if TMA could also detect Mycoplasma genitalium and Trichomonas vaginalis in men a

87 There is increasing concern about Mycoplasma genitalium as a cause of urethritis, cervicit

88 ral pathogens, and the literature supporting Mycoplasma genitalium as an etiology of urethritis is gr

89 Mycoplasma genitalium causes persistent urogenital tract

90 Chlamydia trachomatis and Mycoplasma genitalium coinfections were evaluated using

91 The human pathogen Mycoplasma genitalium employs homologous recombination t

92 Infection with Mycoplasma genitalium has been associated with male and

93 Mycoplasma genitalium has been causally linked with nong

94 -site genital and extragenital screening for Mycoplasma genitalium in 102 asymptomatic Air Force memb

95 Although the pathogenic role of Mycoplasma genitalium in male urethritis is clear, fewer

96 To determine the association between Mycoplasma genitalium infection and female reproductive

97 Mycoplasma genitalium infection was less prevalent in ol

98 Mycoplasma genitalium infection was significantly associ

99 ydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium infection.

100 The prevalence rates of Mycoplasma genitalium infections and coinfections with o

101 Mycoplasma genitalium is a common cause of nongonococcal

102 Mycoplasma genitalium is a common sexually transmitted i

103 Mycoplasma genitalium is a frequent undiagnosed cause of

104 Because Mycoplasma genitalium is a prevalent and emerging cause

105 Mycoplasma genitalium is a sexually transmitted pathogen

106 Mycoplasma genitalium is an emerging sexually transmitte

107 Mycoplasma genitalium is an emerging sexually transmitte

108 Mycoplasma genitalium is an important and emerging agent

109 Mycoplasma genitalium is an important sexually transmitt

110 Mycoplasma genitalium is an underappreciated cause of hu

111 Mycoplasma genitalium is expected to metabolize RNA usin

112 The prevalence of Mycoplasma genitalium is high in vulnerable populations

113 Mycoplasma genitalium is increasingly appreciated as a c

114 Although Mycoplasma genitalium is increasingly recognized as a se

115 The incubation period for NGU caused by Mycoplasma genitalium is probably longer than for NGU ca

116 Mycoplasma genitalium is the smallest self-replicating b

117 Mycoplasma genitalium is very difficult to grow in cultu

118 article lays out the research priorities for Mycoplasma genitalium research agreed upon by the partic

119 on (TMA), residual material was subjected to Mycoplasma genitalium research-use-only TMA.

120 Mycoplasma genitalium samples from cases failing moxiflo

121 Additional Trichomonas vaginalis and Mycoplasma genitalium screening found 17.4% and 23.9% of

122 ements for all viable single-gene disruption Mycoplasma genitalium strains.

123 odel of the life cycle of the human pathogen Mycoplasma genitalium that includes all of its molecular

124 Mycoplasma genitalium treatment failure was extremely co

125 istance and microbiological cure in men with Mycoplasma genitalium urethritis during 2013-2015 and co

126 sive database of the Gram-positive bacterium Mycoplasma genitalium using over 900 sources.

127 The prevalence of Mycoplasma genitalium was 14% and higher in HIV-positive

128 Mycoplasma genitalium was associated with Neisseria gono

129 uary 2015 using the following search terms: (Mycoplasma genitalium) AND (azithromycin OR zithromax OR

130 ith minimal genomes (Buchnera aphidicola and Mycoplasma genitalium).

131 Mycoplasma genitalium, a human pathogen associated with

132 recent bacterial vaginosis (BV) and incident Mycoplasma genitalium, a sexually transmitted bacterium

133 hlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and Trichomonas vaginalis infecti

134 risk for acquiring STIs, the prevalences of Mycoplasma genitalium, Chlamydia trachomatis, Neisseria

135 plasmas, such as the emergent human pathogen Mycoplasma genitalium, developed a complex polar structu

136 Factors associated with prevalent Mycoplasma genitalium, including sociodemographics, repr

137 etween 2000 and 2016, using the search terms Mycoplasma genitalium, M. genitalium, diagnosis, and det

138 's experience building a whole-cell model of Mycoplasma genitalium, we identified several significant

139 citis is aimed at Chlamydia trachomatis, but Mycoplasma genitalium, which also commonly causes undiag

140 tibiotic regimens in a prospective cohort of Mycoplasma genitalium-infected participants, and factors

141 pleted 629,409-bp 'Mnola' genome (Candidatus Mycoplasma girerdii str.

142 qualitatively and quantitatively the role of mycoplasma gliding motility in the colonization pattern

143 etected; however, infection with "Candidatus Mycoplasma haematoparvum" and a potentially novel, but i

144 Mycoplasma haemocanis is a blood pathogen that may cause

145 the complete genome sequence of "Candidatus Mycoplasma haemolamae," an endemic red-cell pathogen of

146 Although mycoplasmas have a paucity of glycosyltransferases and n

147 fections are mostly chronic, suggesting that mycoplasmas have developed means to evade the host immun

148 ogy of the terminal organelles suggests that mycoplasmas have evolved terminal organelles independent

149 %), fungi (10%) and Mycobacterium abscessus, Mycoplasma hominis and Lactobacillus sp. (one each).

150 One had high abundance of Mycoplasma hominis and other had high abundance of an un

151 Mycoplasma hominis and Ureaplasma parvum do not appear t

152 Mycoplasma hominis identification was confirmed using se

153 Invasive and disseminated Mycoplasma hominis infections are well recognized but un

154 Mycoplasma hominis is a commensal genitourinary tract or

155 Mycoplasma hominis isolates were subjected to whole-geno

156 Mycoplasma hominis should be considered a cause of donor

157 Mycoplasma hominis was detected by culture and qPCR in 2

158 Mycoplasma hominis was transmitted through amniotic tiss

159 aginae, Gardnerella vaginalis, lactobacilli, Mycoplasma hominis, and the human albumin gene (for qual

160 eptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum using bro

161 umoniae (MpnEf-Tu), and the porcine pathogen Mycoplasma hyopneumoniae (MhpEf-Tu).

162 ginosa exotoxin A (ntPE), Bacillus globigii, Mycoplasma hyopneumoniae, Listeria monocytogenes, Escher

163 Mycoplasma hyorhinis impacts swine health and production

164 Proteases from Mycoplasma hyorhinis, Legionella pneumophila, Streptococ

165 ncreased cytostatic activity was observed in Mycoplasma hyorhinis-infected human breast carcinoma MCF

166 ycytidine; dFdC) was severely compromised in Mycoplasma hyorhinis-infected tumor cell cultures.

167 The first component, Mycoplasma Ig binding protein (MIB), is an 83-kDa protei

168 The second component, Mycoplasma Ig protease (MIP), is a 97-kDa serine proteas

169 (defined as >/=100 reads/million mapping to mycoplasma in one or more samples).

170 s, our findings suggest that the presence of mycoplasmas in the tumor microenvironment could be a lim

171 ug when it was exposed to the supernatant of mycoplasma-infected cells.

172 ponsible for pulmonary T cell stimulation in mycoplasma-infected mice, and these dendritic cells like

173 in inflammatory infiltrates in the lungs of mycoplasma-infected mice.

174 Here we demonstrate that mycoplasma-infected tumor cells release exosomes (myco+

175 Our results demonstrate that mycoplasma-infected tumor cells release exosomes carryin

176 m and related cytostatic activity of dFdC in mycoplasma-infected tumor cells was therefore also (part

177 umor cell-free but mycoplasma-containing) of mycoplasma-infected tumor cells.

178 These results suggest that mycoplasmas infecting tumor cells can exploit the exosom

179 The prevalence of hemotropic mycoplasma infection (4.7%) was significantly greater in

180 ies into venules in the airways of mice with Mycoplasma infection and that TNFalpha signaling is nece

181 rrent available methods for the diagnosis of Mycoplasma infection, including cultivation, serological

182 al contact for the possibility of hemotropic mycoplasma infection.

183 hanges in lipid content of cell lines due to mycoplasma infection.

184 Mycoplasma infections include a spectrum of clinical man

185 a model of the vertebrate immune response to mycoplasma infections, and use it to identify which path

186 at molecular-level study of how MG and other mycoplasmas interact with a host's non-specific and infl

187 n the number of repeats is low, e.g., 5, the mycoplasma is killed by complement when the cells are di

188 the number of repeats is high, e.g., 40, the mycoplasma is resistant to lysis by complement but does

189 o amplification was obtained from 71 related Mycoplasma isolates or from the Acholeplasma or the Past

190 Mycoplasma leucyl-tRNA synthetases (LeuRSs) have been id

191 es belonging to a novel, as-yet-uncultivated mycoplasma (lineage 'Mnola') in the oral cavity of a pre

192 Like other polarized mycoplasmas, M. penetrans and M. iowae have terminal org

193 < 0.001) were significantly associated with mycoplasma-mapped read counts.

194 Ninety percent of mycoplasma-mapped reads aligned to ribosomal RNA.

195 rotein-A (SP-A) binds live M. pneumoniae and mycoplasma membrane fractions (MMF) with high affinity.

196 Mycoplasma mobile carries out gliding motility using a n

197 In one case, Mycoplasma mobile leucyl-tRNA synthetase (LeuRS) is uniq

198 in that clears mischarged tRNAs are missing (Mycoplasma mobile) or highly degenerate (Mycoplasma syno

199 om that of other gliding bacteria, including Mycoplasma mobile.

200 Members of the Mycoplasma mycoides cluster are among the most virulent

201 genetically engineering the AT-rich, 1.1 Mb Mycoplasma mycoides genome in yeast encouraged us to exp

202 e the 1079-kilobase pair synthetic genome of Mycoplasma mycoides JCVI-syn1.0.

203 reported using two closely related bacteria, Mycoplasma mycoides subsp. capri (Mmc) and Mycoplasma ca

204 Mycoplasma mycoides subsp. capri (Mmc) and subsp. mycoid

205 tidase, confers the proteolytic phenotype in Mycoplasma mycoides subsp. capri GM12.

206 Mycoplasma mycoides subsp. mycoides small colony biotype

207 ious respiratory disease of cattle caused by Mycoplasma mycoides subsp. mycoides.

208 nally characterize a two-protein system from Mycoplasma mycoides subspecies capri that is involved in

209 Mycoplasma mycoides subspecies mycoides Small Colony (Mm

210 of the small-ribosomal subunit (16S) RNA of Mycoplasma mycoides, by combining the CRISPR/Cas9 system

211 asses of antimicrobial are effective against mycoplasmas, namely tetracyclines, fluoroquinolones and

212 cally in infectiousness or susceptibility to Mycoplasma ovipneumoniae, an agent responsible for bigho

213 We detected persistent infections of Mycoplasma ovipneumoniae, the primary causative agent of

214 Based upon DNA sequence analysis, a Mycoplasma ovis-like species was the most prevalent orga

215 The very CpG poor Mycoplasma penetrans and its constitutively active CpG-s

216 nisms where translation is more accurate, as Mycoplasma PheRS failed to support Escherichia coli grow

217 Mycoplasma PheRS was found to lack canonical editing act

218 e >2 was found in 2 subjects (osteomyelitis, Mycoplasma pneumonia).

219 Using a murine model of mycoplasma pneumonia, lymphocyte responses, specifically

220 Mycoplasma pneumoniae (Mp) frequently colonizes the airw

221 Mycoplasma pneumoniae (Mp) infections cause tracheobronc

222 athogens Staphylococcus aureus (SaEf-Tu) and Mycoplasma pneumoniae (MpnEf-Tu), and the porcine pathog

223 urine pneumococcal and legionella antigens, Mycoplasma pneumoniae and Chlamydia pneumoniae antibodie

224 these processes in the pathogenic bacterium Mycoplasma pneumoniae and its close relatives have also

225 mnose was detected in the d configuration in Mycoplasma pneumoniae and Mycoplasma pulmonis, and in bo

226 n technology, was used to initially identify Mycoplasma pneumoniae as the causative agent in this out

227 Mycoplasma pneumoniae continues to be a significant caus

228 Mycoplasma pneumoniae exhibits a novel form of gliding m

229 preceding respiratory tract infections with Mycoplasma pneumoniae have been reported in some cases,

230 ectrum of neurologic disease attributable to Mycoplasma pneumoniae in children is incompletely unders

231 Studies on Mycoplasma pneumoniae in Thailand have focused on urban

232 onic eosinophilic pneumonia complicated with Mycoplasma pneumoniae infection was diagnosed on the bas

233 ting human herpes virus (HHV1-HHV7), HEV, or Mycoplasma pneumoniae infections using throat swab virus

234 iratory distress syndrome (CARDS) toxin from Mycoplasma pneumoniae is a 591-amino-acid virulence fact

235 Mycoplasma pneumoniae is a leading cause of community-ac

236 Mycoplasma pneumoniae is a leading cause of respiratory

237 The cell wall-less prokaryote Mycoplasma pneumoniae is a major cause of community-acqu

238 Mycoplasma pneumoniae is a major human respiratory patho

239 Mycoplasma pneumoniae is a significant human respiratory

240 Mycoplasma pneumoniae is an atypical bacterial respirato

241 Mycoplasma pneumoniae is an extracellular pathogen that

242 Mycoplasma pneumoniae is an important cause of respirato

243 Macrolide-resistant Mycoplasma pneumoniae is an increasing problem worldwide

244 Early distinction between severe Mycoplasma pneumoniae pneumonia (MPP) and mild MPP is st

245 t of detection was </=88 CFU/reaction for 10 Mycoplasma pneumoniae reference strains.

246 cell cultures infected with a PyNP-deficient Mycoplasma pneumoniae strain.

247 Mycoplasma pneumoniae was detected in 1.9% of patients a

248 Mycoplasma pneumoniae was more common among children 5 y

249 lung inflammatory responses to bacteria (eg, Mycoplasma pneumoniae) involved in lung disease exacerba

250 e increased inflammatory response induced by Mycoplasma pneumoniae, a pathogen known to exacerbate as

251 Mycoplasma pneumoniae, long appreciated as one of the tr

252 mophilus influenzae, Neisseria meningitidis, Mycoplasma pneumoniae, Mycobacterium tuberculosis, and B

253 l of antimicrobial susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasm

254 six bacteria that have varied genome sizes (Mycoplasma pneumoniae, Treponema pallidum, Helicobacter

255 ly become available for Escherichia coli and Mycoplasma pneumoniae, yielding 443 and 116 heteromultim

256 ld-type copies, including the ruvA gene from Mycoplasma pneumoniae.

257 is (MLVA) method for the molecular typing of Mycoplasma pneumoniae.

258 Proteomic analysis identified mycoplasma proteins in exosomes that potentially contrib

259 remodeling in the respiratory tract by using Mycoplasma pulmonis infection as a model of sustained in

260 ANG2 drove vascular remodeling during Mycoplasma pulmonis infection by acting as a Tie2 antago

261 o these changes in airway inflammation after Mycoplasma pulmonis infection in mice.

262 in airway lymphatics at 14 and 28 days after Mycoplasma pulmonis infection of the respiratory tract.

263 r baseline conditions and 3 to 28 days after Mycoplasma pulmonis infection, using prospero heomeobox

264 The infection of mice with Mycoplasma pulmonis is a model for studying chronic myco

265 d configuration in Mycoplasma pneumoniae and Mycoplasma pulmonis, and in both the d and l configurati

266 ut were efficiently catabolized (removed) by mycoplasma PyNP.

267 Proteins from several species of Mycoplasma reacted with a glycoprotein stain, and the mu

268 ain were annotated using the fully annotated Mycoplasma reference genome.

269 teria classified as Mollicutes, and known as mycoplasma-related endobacteria (MRE).

270 traits associated with enhanced virulence in Mycoplasmas, relative to isolates from sham-treated bird

271 acrophages (HD-11) with TECs exposed to live mycoplasma revealed the upregulation of several proinfla

272 Here, we found VP of Mycoplasma, Rhizobiales, and Rickettsiales showed signif

273 case where metagenomics was used to identify Mycoplasma salivarium as a novel PJI pathogen in a patie

274 Mycoplasma salivarium infections outside the oral cavity

275 , this is the first report of empyema due to Mycoplasma salivarium.

276 ns with Bartonella quintana and a hemotropic Mycoplasma sp. in a research colony of cynomolgus monkey

277 use it has been reported that some commensal mycoplasma species (including M. hyorhinis) preferential

278 Protein M as well as its orthologs in other Mycoplasma species could become invaluable reagents in t

279 the most virulent and economically important Mycoplasma species for poultry worldwide.

280 oduction/cytotoxicity and virulence for this Mycoplasma species in its natural host.

281 An unknown Mycoplasma species plays a role in some of these transfo

282 , but incompletely characterized, hemotropic Mycoplasma species was also documented.

283 oss-reactivity was observed against 17 other Mycoplasma species, 27 common respiratory agents, or hum

284 ified lineage sister to the hominis group of Mycoplasma species.

285 ence in vivo have never been assessed in any Mycoplasma species.

286 s and other had high abundance of an unknown Mycoplasma species.

287 unique compared to those identified in other mycoplasma species.

288 ion and sequencing revealed a putative novel mycoplasma species.

289 fected mice were most capable of stimulating mycoplasma-specific CD4(+) Th cell responses in vitro.

290 erwent routine processing with subculture on Mycoplasma-specific Hayflick agar.

291 arthropod vectors that can harbor hemotropic Mycoplasma spp. should be considered during epidemiologi

292 ransplanted into recipient cells yielded two mycoplasma strains.

293 Several mycoplasmas, such as the emergent human pathogen Mycopla

294 ed from (AG)n-Di-SSRs between VP and N_VP in Mycoplasma suggested the potential role of (AG)n-Di-SSRs

295 ng (Mycoplasma mobile) or highly degenerate (Mycoplasma synoviae).

296 tients with different prokaryotes (including mycoplasmas), the data presented here may be of relevanc

297 There appears to be selective pressure for mycoplasmas to retain the genes needed for glycerol meta

298 No cross-reactions were detected with other mycoplasmas, ureaplasmas, other bacterial species, virus

299 bacterial genera Mannheimia, Moraxella, and Mycoplasma were significantly higher in diseased versus

300 Genital mycoplasmas, which can be vertically transmitted, have b